A strategy for rational design of fully synthetic glycopeptide conjugate vaccines
about
Phase I clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b in human adult volunteers.Antigenicity and immunogenicity of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b.A modular synthetic route to size-defined immunogenic Haemophilus influenzae b antigens is key to the identification of an octasaccharide lead vaccine candidate.
P2860
A strategy for rational design of fully synthetic glycopeptide conjugate vaccines
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
A strategy for rational design of fully synthetic glycopeptide conjugate vaccines
@ast
A strategy for rational design of fully synthetic glycopeptide conjugate vaccines
@en
A strategy for rational design of fully synthetic glycopeptide conjugate vaccines
@nl
type
label
A strategy for rational design of fully synthetic glycopeptide conjugate vaccines
@ast
A strategy for rational design of fully synthetic glycopeptide conjugate vaccines
@en
A strategy for rational design of fully synthetic glycopeptide conjugate vaccines
@nl
prefLabel
A strategy for rational design of fully synthetic glycopeptide conjugate vaccines
@ast
A strategy for rational design of fully synthetic glycopeptide conjugate vaccines
@en
A strategy for rational design of fully synthetic glycopeptide conjugate vaccines
@nl
P2093
P2860
P1476
A strategy for rational design of fully synthetic glycopeptide conjugate vaccines
@en
P2093
P2860
P304
P407
P577
1997-12-01T00:00:00Z